DOI: https://dx.doi.org/10.18565/pharmateca.2022.4.18-25
Л.Ю. Моргунов
Медицинский институт, Российский университет дружбы народов, Москва, Россия
1. Hart P.A., Bellin M.D., Andersen D.K., et al. Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer(CPDPC). Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer. Lancet Gastroenterol Hepatol. 2016;1(3):226-37. Doi: 10.1016/S2468-1253(16)30106-6. 2. Venturi S. Cesium in Biology, Pancreatic Cancer, and Controversy in High and Low Radiation Exposure Damage-Scientific, Environmental, Geopolitical, and Economic Aspects. Int J Environ Res Public Health. 2021;18(17):8934. Doi: 10.3390/ijerph18178934. 3. Bhattamisra S.K., Siang T.C., Rong C.Y., et al. Type-3c Diabetes Mellitus, Diabetes of Exocrine Pancreas - An Update. Curr Diabetes Rev. 2019;15(5):382-94. Doi: 10.2 1 74/15733 998 15666190115145702. 4. Ewald N., Bretzel R.G. Diabetes mellitus secondary to pancreatic diseases (Type 3c)-are we neglecting an important disease? Eur J Intern Med. 2013;24(3):203-6. Doi: 10.1016/j. ejim.2012.12.017. 5. Wynne K., Devereaux B., Dornhorst A. Diabetes of the exocrine pancreas. J Gastroenterol Hepatol. 2019;34(2):346-54. Doi: 10.1111/jgh.14451. 6. Cui Y., Andersen D.K. Pancreatogenic diabetes: special considerations for management. Pancreatology. 2011;11(3):279-94. Doi: 10.1159/000329188 7. Singh V.K., Haupt M.E., Geller D.E., et al. Less common etiologies of exocrine pancreatic insufficiency. World J Gastroenterol. 2017;23(39):7059-76. Doi: 10.3748/wjg. v23. i39.7059. 8. Petrov M.S. Post-pancreatitis diabetes mellitus: prime time for secondary disease. Eur J Endocrinol. 2021;184(4):R137-R149. Doi: 10.1530/EJE-20-0468. 9. Woodmansey C., McGovern A.P., McCullough K.A., et al. Incidence, Demographics, and Clinical Characteristics of Diabetes of the Exocrine Pancreas (Type 3c): A Retrospective Cohort Study. Diabetes Care. 2017;40(11):1486-93. Doi: 10.2337/dc17-0542. 10. Yadav D., Whitcomb D.C., Tang G., et al., North American Pancreatitis Studies Consortium. Autoimmunity May Explain Diabetes in a Subset of Patients with Recurrent Acute and Chronic Pancreatitis: A Pilot Study. Clin Gastroenterol Hepatol. 2021 Nov 16;S1542-3565(21)01223- 24. Doi: 10.1016/j.cgh.2021.11.011. 11. Hart P.A., Bradley D., Conwell D.L., et al. Diabetes following acute pancreatitis. Lancet Gastroenterol Hepatol. 2021;6(8):668-75. Doi: 10.1016/ S2468-1253(21)00019-4. 12. Richardson A., Park W.G. Acute pancreatitis and diabetes mellitus: a review. Korean J Intern Med. 2021;36(1):15-24. Doi: 10.3904/ kjim.2020.505. 13. Cho J., Scragg R., Petrov M.S. Postpancreatitis Diabetes Confers Higher Risk for Pancreatic Cancer Than Type 2 Diabetes: Results from a Nationwide Cancer Registry. Diabetes Care. 2020;43(9):2106- 12. Doi: 10.2337/dc20-0207. 14. Scholten L., Mungroop T.H., Haijtink S.A.L., et al. New-onset diabetes after pancreatoduodenectomy: A systematic review and meta-analysis. Surgery. 2018 May 17; S0039-6060(18)30081-3. Doi: 10.1016/j. surg.2018.01.024. 15. Wu L., Nahm C.B., Jamieson N.B., et al. Risk factors for development of diabetes mellitus (Type 3c) after partial pancreatectomy: A systematic review. Clin Endocrinol (Oxf). 2020;92(5):396- 406. Doi: 10.1111/cen.14168.18. 16. Yu J., Sun R., Han X., Liu Z. New-Onset Diabetes Mellitus After Distal Pancreatectomy: A Systematic Review and Meta-Analysis. J Laparoendosc Adv Surg Tech A.2020;30(11):1215-22. Doi: 10.1089/lap.2020.0090. 17. Malka D., Hammel P., Sauvanet A., et al. Risk factors for diabetes mellitus in chronic pancreatitis. Gastroenterology. 2000;119(5):1324-32. Doi: 10.1053/gast.2000.19286. 18. Melki G., Laham L., Karim G., et al. Chronic Pancreatitis Leading to Pancreatogenic Diabetes Presenting in Diabetic Ketoacidosis: A Rare Entity. Gastroenterology Res. 2019;12(4):208-210. Doi: 10.14740/gr1203. 19. Ewald N., Hardt P.D. Diagnosis and treatment of diabetes mellitus in chronic pancreatitis. World J Gastroenterol. 2013;19(42):7276-81. Doi: 10.3748/wjg.v19.i42.7276. 20. Chakravarthy M.D., Thangaraj P., Saraswathi S. Missed Case of Pancreatogenic Diabetes Diagnosed Using Ultrasound. J Med Ultrasound. 2021;29(3):218-20. Doi: 10.4103/JMU. JMU_138_20. 21. Talukdar R., Sarkar P., Jakkampudi A., et al. The gut microbiome in pancreatogenic diabetes differs from that of Type 1 and Type 2 diabetes. Sci Rep. 2021;11(1):10978. Doi: 10.1038/s41598- 021-90024-w. 22. Kempeneers M.A., Issa Y., Ali U.A., et al, Dutch Pancreatitis Study Group. A Classification Algorithm for Types of Diabetes in Chronic Pancreatitis Using Epidemiological Characteristics: Outcome of a Longitudinal Cohort Study. Pancreas. 2021;50(10):1407-14. Doi: 10.1097/ MPA.0000000000001937. 23. Rickels M.R., Bellin M., Toledo F.G.S., et al.; PancreasFest Recommendation Conference Participants. Detection, evaluation and treatment of diabetes mellitus in chronic pancreatitis: recommendations from PancreasFest 2012. Pancreatology. 2013;13(4):336-42. Doi: 10.1016/j.pan.2013.05.002 24. Nagpal S.J.S., Bamlet W.R., Kudva Y.C., Chari S.T. Comparison of Fasting Human Pancreatic Polypeptide Levels Among Patients with Pancreatic Ductal Adenocarcinoma, Chronic Pancreatitis, and Type 2 Diabetes Mellitus. Pancreas. 2018;47(6):738-41. Doi: 10.1097/ MPA.0000000000001077. 25. Donovan A.L., Furlan A., Borhan A.A., et al. Evaluation of clinical and imaging biomarkers for the prediction of new onset diabetes following pancreatic resection. 2021;46(6):2628-36. Doi: 10.1007/s00261-020-02943-3. 26. Oldfield L., Evans A., Rao R.G., et al. Blood levels of adiponectin and IL-1Ra distinguish type 3c from type 2 diabetes: Implications for earlier pancreatic cancer detection in new-onset diabetes. EBioMedicine. 2022;75:103802. Doi: 10.1016/j.ebiom.2021.103802. 27. Sliwinska-Mosson M., MilnerowiczS., Milnerowicz H. Diabetes mellitus secondary to pancreatic diseases (type 3c): The effect of smoking on the exocrine-endocrine interactions of the pancreas. Diab Vasc Dis Res. 2018;15(3):243-59. Doi: 10.1177/1479164118764062. 28. Duggan S.N., O’Connor D.B., Antanaitis A., et al. Metabolic dysfunction and diabetes mellitus during long-term follow-up of severe acute pancreatitis: A case-matched study. Pancreatolog. 2020;20(5):813-21. Doi: 10.1016/j. pan.2020.03.016. 29. Yoon B.H., Ang S.M., Alabd A., et al. Pancreatic Cancer-Associated Diabetes is Clinically Distinguishable from Conventional Diabetes. J Surg Res. 2021;261:215-25. Doi: 10.1016/j. jss.2020.12.015. 30. Lin Y.K., Johnston P.C., Arce K., Hatipoglu B.A. Chronic Pancreatitis and Diabetes Mellitus. Curr Treat Options Gastroenterol. 201513(3):319- 31. Doi: 10.1007/s11938-015-0055-x. 31. Johnston P.C., Thompson J., Mckee A., et al. Diabetes and Chronic Pancreatitis: Considerations in the Holistic Management of an Often-Neglected Disease. J Diabetes Res. 2019;2019:2487804. Doi: 10.1155/2019/2487804. 32. Petrov M.S. Post-pancreatitis diabetes mellitus: investigational drugs in preclinical and clinical development and therapeutic implications. Expert Opin Investig Drugs. 2021;30(7):737-47. Doi: 10.1080/13543784.2021.1931118. 33. Ramalho G.X., Dytz M.G. Diabetes of the Exocrine Pancreas Related to Hereditary Pancreatitis, an Update. Curr Diab Rep. 2020;20(6):16. Doi: 10.1007/s11892-020-01299-8 34. Cho J., Scragg R., Pandol S.J., et al. Antidiabetic Medications and Mortality Risk in Individuals with Pancreatic Cancer-Related Diabetes and Postpancreatitis Diabetes: A Nationwide Cohort Study. Diabetes Care. 2019;42(9):1675-83. Doi: 10.2337/dc19-0145 35. Lin Y.K., Faiman C., Johnston P.C., et al. Spontaneous hypoglycemia after islet autotransplantation for chronic pancreatitis. J Clin Endocrinol & Metab. 2016;101(10):3669-75. Doi: 10.1210/jc.2016-2111. 36. Rickels M.R., Robertson R.P. Pancreatic Islet Transplantation in Humans: Recent Progress and Future Directions. Endocr Rev. 2019;40(2):631- 68. Doi: 10.1210/er.2018-00154. 37. Memon B., Abdelalim E.M. Stem Cell Therapy for Diabetes: Beta cells versus pancreatic rogenitors. Cells. 2020;9(2):283. Doi: 10.3390/ cells9020283.
Автор для связи: Леонид Юльевич Моргунов, д.м.н., профессор, профессор кафедры госпитальной терапии с курсом эндокринологии, гематологии и клинической лабораторной диагностики Медицинского института, Российский университет дружбы народов, Москва, Россия; morgunov.l.y@mail.ru, https://orcid.org/0000-0002-6608-2825